Uncategorized

Monodisperse heterobifunctional PEGs of higher molecular weight for advanced pharmaceutical applications

by
Polypure monodisperse PEG derivative

Erik Agner, CEO Polypure AS The COVID-19 pandemic created a demand for a fast response to provide vaccines to a concerned world population. In this post, we will describe how Polypure developed monodisperse, heterobifunctional PEGs of higher molecular weights for advanced pharmaceutical applications based on the COVID-19 vaccine R&D project. The technology of mRNA incorporated … Read more

How can monodisperse PEG enhance drug development?

by
Polypure monodisperse PEG enhance drug development

In our recent article published on the prestigious Chemistry World website, we explore how monodisperse PEG from Polypure, with a defined and uniform molecular weight, enables a higher level of precision in drug development and bioconjugation. By eliminating molecular heterogeneity, monodisperse PEG supports more reliable characterisation, improved process control, and more consistent outcomes across research … Read more

Polypure is visiting CPHI Frankfurt 2025

by
Polypure_CPHI-Frankfurt

Polypure AS – the PEG specialist – is visiting CPHI Frankfurt 2025 on 28th-30th October. We are there to discover, connect and upskill! Will we see you there? Contact us at info@polypure.no to arrange a meeting!

2 kDa PEGs in our Portfolio

by
Polypure 2 kDa PEGs

Polypure has recently expanded its offer in 2 kDa PEGs. Our catalogue is now updated and a list of 2 kDa products can be found here: https://polypure.com/product-list/peg-2000/

Ph.D. defense at Polypure

by
From Left: Professor Magne Olav Sydnes, Yomkippur Perez, CEO Erik Agner

On Thursday 3rd July 2025, our colleague Yomkippur Perez defended her Ph.D. thesis at the University of Stavanger entitled “Monodisperse Poly(ethylene glycol) Derivatives for Pharmaceutical Applications”.